Literature DB >> 16817854

Mixed-type noncompetitive inhibition of anthrax lethal factor protease by aminoglycosides.

Petr Kuzmic1, Lynne Cregar, Sherri Z Millis, Mark Goldman.   

Abstract

We report a detailed kinetic investigation of the aminoglycosides neomycin B and neamine as inhibitors of the lethal factor protease from Bacillus anthracis. Both inhibitors display a mixed-type, noncompetitive kinetic pattern, which suggests the existence of multiple enzyme-inhibitor binding sites or the involvement of multiple structural binding modes at the same site. Quantitative analysis of the ionic strength effects by using the Debye-Hückel model revealed that the average interionic distance at the point of enzyme-inhibitor attachment is likely to be extremely short, which suggests specific, rather than nonspecific, binding. Only one ion pair seems to be involved in the binding process, which suggests the presence of a single binding site. Combining the results of our substrate competition studies with the ionic strength effects on the apparent inhibition constant, we propose that aminoglycoside inhibitors, such as neomycin B, bind to the lethal factor protease from B. anthracis in two different structural orientations. These results have important implications for the rational design of lethal factor protease inhibitors as possible therapeutic agents against anthrax. The strategies and methods we describe are general and can be employed to investigate in depth the mechanism of inhibition by other bioactive compounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16817854     DOI: 10.1111/j.1742-4658.2006.05316.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  10 in total

1.  Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.

Authors:  Lynne Cregar-Hernandez; Guan-Sheng Jiao; Alan T Johnson; Axel T Lehrer; Teri Ann S Wong; Stephen A Margosiak
Journal:  Antivir Chem Chemother       Date:  2011-05-12

Review 2.  Designing inhibitors of anthrax toxin.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Expert Opin Drug Discov       Date:  2014-01-22       Impact factor: 6.098

3.  A novel pharmacophore model for the design of anthrax lethal factor inhibitors.

Authors:  Hongbin Yuan; Sherida L Johnson; Li-Hsing Chen; Jun Wei; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2010-06-21       Impact factor: 2.817

4.  Biochemical and structural analysis of an Eis family aminoglycoside acetyltransferase from bacillus anthracis.

Authors:  Keith D Green; Tapan Biswas; Changsoo Chang; Ruiying Wu; Wenjing Chen; Brian K Janes; Dominika Chalupska; Piotr Gornicki; Philip C Hanna; Oleg V Tsodikov; Andrzej Joachimiak; Sylvie Garneau-Tsodikova
Journal:  Biochemistry       Date:  2015-05-12       Impact factor: 3.162

5.  Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.

Authors:  Stacie M Bratton; Carrie M Mosher; Farid Khallouki; Moshe Finel; Michael H Court; Jeffery H Moran; Anna Radominska-Pandya
Journal:  J Pharmacol Exp Ther       Date:  2011-10-04       Impact factor: 4.030

6.  Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease.

Authors:  Suzanne M Tomlinson; Stanley J Watowich
Journal:  Biochemistry       Date:  2008-10-15       Impact factor: 3.162

7.  High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.

Authors:  Thibaut Pelat; Michael Hust; Emmanuelle Laffly; Florence Condemine; Chantal Bottex; Dominique Vidal; Marie-Paule Lefranc; Stefan Dübel; Philippe Thullier
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

8.  Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO2+) chelates.

Authors:  Jason Hon; Michelle S Hwang; Meara A Charnetzki; Issra J Rashed; Patrick B Brady; Sarah Quillin; Marvin W Makinen
Journal:  J Biol Inorg Chem       Date:  2017-10-25       Impact factor: 3.358

9.  Equilibrium model selection: dTTP induced R1 dimerization.

Authors:  Tomas Radivoyevitch
Journal:  BMC Syst Biol       Date:  2008-02-04

10.  Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sites.

Authors:  Sebastiano Bellanca; Robert L Summers; Max Meyrath; Anurag Dave; Megan N Nash; Martin Dittmer; Cecilia P Sanchez; Wilfred D Stein; Rowena E Martin; Michael Lanzer
Journal:  J Biol Chem       Date:  2014-11-06       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.